sb 216763 has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carson, DA; Corr, M; Cottam, HB; Kipps, TJ; Leoni, LM; Lu, D; Sen, M; Tawatao, R; Zhao, Y | 1 |
1 other study(ies) available for sb 216763 and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Activation of the Wnt signaling pathway in chronic lymphocytic leukemia.
Topics: B-Lymphocytes; beta Catenin; Cell Survival; Cells, Cultured; Cyclin D1; Cytoskeletal Proteins; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Maleimides; Multigene Family; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Trans-Activators; Transcription Factors; Wnt Proteins; Zebrafish Proteins | 2004 |